FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2157764330> ?p ?o ?g. }

• W2157764330 abstract "New prognostic markers may be of value in determining survival and informing decisions of adjuvant treatment in the heterogeneous group of soft tissue sarcomas known as malignant fibrous sarcomas (MFS). Increased CD44 expression has been associated with a better outcome in cancers such as bladder tumors and could potentially relate to cell-cell interaction as a marker for potential invasion/metastasis. The aim of this pilot study was to determine if there is a correlation between the expression rate of CD44 in adult patients with MFS and clinical outcomes.The clinical outcome of 34 adult MFS patients (19 males and 15 females, average age 62 years, median 63 years, range: 38-88 years) who underwent surgical treatment were evaluated. Twenty-five of these patients had additional adjuvant radiotherapy. Extracted RNA from sarcoma tissues was used to measure the transcripts of CD44s (standard form) and isoform expression.The pooled data for each variant of CD44 was divided in half at the median expression value into two equally sized groups (low and high). Survival modeling and multivariate analysis were used with these two groups to determine if there were differences in survival times and whether this was independent of known factors such as tumor stage/grade, patient age and resection margin status.High CD44s and low of CD44v6 expression significantly correlated with an improved outcome (P <0.05 and P <0.02, respectively) whereas CD44v8 and hCD44 (isoforms) did not. Differences in survival were apparent within 6-12 months of operation with >30% difference in survival between low/high expressions at 5 years. These finding were independent of the other measured MFS survival predictors, though the group was homogenous.High CD44s and low CD44v6 expression may be an independent predictor of improved survival in MFS patients in this pilot data. This is contrary to other MFS data, which did not account for the CD44 isoforms but is confirmed by data from other cancer types. Further investigation is needed to confirm CD44 isoform expression data as a relevant survival biomarker and whether it could be used to inform clinical decisions such as adjuvant therapy." @default.
• W2157764330 created "2016-06-24" @default.
• W2157764330 creator A5012213424 @default.
• W2157764330 creator A5017329335 @default.
• W2157764330 creator A5026967516 @default.
• W2157764330 creator A5039660568 @default.
• W2157764330 creator A5041516656 @default.
• W2157764330 creator A5056542379 @default.
• W2157764330 creator A5059284457 @default.
• W2157764330 creator A5060729994 @default.
• W2157764330 creator A5073827670 @default.
• W2157764330 creator A5076040219 @default.
• W2157764330 creator A5082280101 @default.
• W2157764330 date "2014-02-03" @default.
• W2157764330 modified "2023-09-26" @default.
• W2157764330 title "Increased CD44s and decreased CD44v6 RNA expression are associated with better survival in myxofibrosarcoma patients: a pilot study" @default.
• W2157764330 cites W1493591863 @default.
• W2157764330 cites W1535028213 @default.
• W2157764330 cites W1972039193 @default.
• W2157764330 cites W1979443344 @default.
• W2157764330 cites W1983233269 @default.
• W2157764330 cites W1983884187 @default.
• W2157764330 cites W1985585224 @default.
• W2157764330 cites W2001870826 @default.
• W2157764330 cites W2010885734 @default.
• W2157764330 cites W2022877059 @default.
• W2157764330 cites W2026024971 @default.
• W2157764330 cites W2037100155 @default.
• W2157764330 cites W2043051880 @default.
• W2157764330 cites W2045004770 @default.
• W2157764330 cites W2047437874 @default.
• W2157764330 cites W2061046382 @default.
• W2157764330 cites W2096956699 @default.
• W2157764330 cites W2142790807 @default.
• W2157764330 cites W2151293992 @default.
• W2157764330 cites W4293241248 @default.
• W2157764330 doi "https://doi.org/10.1186/2047-783x-19-6" @default.
• W2157764330 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3942188" @default.
• W2157764330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24491153" @default.
• W2157764330 hasPublicationYear "2014" @default.
• W2157764330 type Work @default.
• W2157764330 sameAs 2157764330 @default.
• W2157764330 citedByCount "15" @default.
• W2157764330 countsByYear W21577643302014 @default.
• W2157764330 countsByYear W21577643302015 @default.
• W2157764330 countsByYear W21577643302016 @default.
• W2157764330 countsByYear W21577643302017 @default.
• W2157764330 countsByYear W21577643302018 @default.
• W2157764330 countsByYear W21577643302019 @default.
• W2157764330 countsByYear W21577643302020 @default.
• W2157764330 countsByYear W21577643302021 @default.
• W2157764330 countsByYear W21577643302022 @default.
• W2157764330 crossrefType "journal-article" @default.
• W2157764330 hasAuthorship W2157764330A5012213424 @default.
• W2157764330 hasAuthorship W2157764330A5017329335 @default.
• W2157764330 hasAuthorship W2157764330A5026967516 @default.
• W2157764330 hasAuthorship W2157764330A5039660568 @default.
• W2157764330 hasAuthorship W2157764330A5041516656 @default.
• W2157764330 hasAuthorship W2157764330A5056542379 @default.
• W2157764330 hasAuthorship W2157764330A5059284457 @default.
• W2157764330 hasAuthorship W2157764330A5060729994 @default.
• W2157764330 hasAuthorship W2157764330A5073827670 @default.
• W2157764330 hasAuthorship W2157764330A5076040219 @default.
• W2157764330 hasAuthorship W2157764330A5082280101 @default.
• W2157764330 hasBestOaLocation W21577643301 @default.
• W2157764330 hasConcept C10515644 @default.
• W2157764330 hasConcept C121608353 @default.
• W2157764330 hasConcept C126322002 @default.
• W2157764330 hasConcept C136948725 @default.
• W2157764330 hasConcept C142724271 @default.
• W2157764330 hasConcept C143998085 @default.
• W2157764330 hasConcept C146357865 @default.
• W2157764330 hasConcept C1491633281 @default.
• W2157764330 hasConcept C151730666 @default.
• W2157764330 hasConcept C2776283816 @default.
• W2157764330 hasConcept C2777982462 @default.
• W2157764330 hasConcept C2778256501 @default.
• W2157764330 hasConcept C2778629024 @default.
• W2157764330 hasConcept C2778913397 @default.
• W2157764330 hasConcept C2780932548 @default.
• W2157764330 hasConcept C38180746 @default.
• W2157764330 hasConcept C54355233 @default.
• W2157764330 hasConcept C71924100 @default.
• W2157764330 hasConcept C86803240 @default.
• W2157764330 hasConceptScore W2157764330C10515644 @default.
• W2157764330 hasConceptScore W2157764330C121608353 @default.
• W2157764330 hasConceptScore W2157764330C126322002 @default.
• W2157764330 hasConceptScore W2157764330C136948725 @default.
• W2157764330 hasConceptScore W2157764330C142724271 @default.
• W2157764330 hasConceptScore W2157764330C143998085 @default.
• W2157764330 hasConceptScore W2157764330C146357865 @default.
• W2157764330 hasConceptScore W2157764330C1491633281 @default.
• W2157764330 hasConceptScore W2157764330C151730666 @default.
• W2157764330 hasConceptScore W2157764330C2776283816 @default.
• W2157764330 hasConceptScore W2157764330C2777982462 @default.
• W2157764330 hasConceptScore W2157764330C2778256501 @default.
• W2157764330 hasConceptScore W2157764330C2778629024 @default.
• W2157764330 hasConceptScore W2157764330C2778913397 @default.
• W2157764330 hasConceptScore W2157764330C2780932548 @default.
• W2157764330 hasConceptScore W2157764330C38180746 @default.

• next